Abstract Details
Shihua Wen, PhD
(Novartis)
PRESENTER |
Dr. Wen has received personal compensation for serving as an employee of novartis. |
Shuu-Jiun Wang, MD | Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Norvatis. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer, Taiwan. The institution of Dr. Wang has received research support from Eli-Lilly. The institution of Dr. Wang has received research support from Norvatis. |
Byung-kun Kim, MD (Eulji Hospital, Dept of Neurology) | Dr. Kim has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Wendy Su | Prof. Su has received personal compensation for serving as an employee of Novartis. Prof. Su has received stock or an ownership interest from Novartis. |
No disclosure on file |